NANCY ARIWODO: Open Payments
NPI 1376169979 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $260 |
| Alkermes, Inc. | 2 | $51 |
| Tris Pharma Inc | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| ABBVIE INC. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
Products named: INGREZZA, ARISTADA, Onyda XR, COBENFY, VRAYLAR, AUSTEDO XR, ERZOFRI EXTENDED-RELEASE.
Industry payments across TX — which companies pay providers there.
